Form 4: LeMaitre Vascular Director Dividend Equivalent Accrual
Statement of Changes in Beneficial Ownership
Director John James O'Connor reported the accrual of dividend equivalent rights related to existing equity awards.
Summary
- Director John James O'Connor received a total of 4.0705 additional dividend equivalent rights (DERs) on June 4, 2026.
- These rights accrued on previously granted restricted stock units (RSUs) and performance share units (PSUs).
- Each DER represents the economic equivalent of one share of LeMaitre Vascular common stock.
- The accruals are tied to equity awards granted between December 2023 and December 2025.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral, routine administrative filing with no impact on the company's fundamental outlook.
Positives
- Reflects the ongoing accumulation of equity-based compensation for a board member, aligning interests with shareholders.
Negatives
- None identified; this is a routine administrative filing regarding dividend reinvestment.
Risks
- None identified; this filing pertains to standard equity compensation adjustments.
Future Outlook
The filing does not provide forward-looking guidance regarding company operations or financial performance.
Industry Context
StockSavvy.ai notes that this is a standard regulatory disclosure for medical device companies, indicating routine maintenance of director equity compensation plans rather than a strategic shift.
Comparison to Industry Standards
- The accrual of dividend equivalent rights is a standard practice among S&P 600 and mid-cap medical device companies to ensure directors are not economically disadvantaged by dividend payments.
- The reporting of these rights via Form 4 is consistent with SEC requirements for Section 16 reporting persons.
Stakeholder Impact
- Minimal impact on shareholders as this represents a standard adjustment to existing director compensation packages.
Next Steps
- The director will continue to hold these rights until the underlying equity awards vest.
Key Dates
| Date | Description |
|---|---|
| 12/08/2023 | Original grant date for initial RSU and PSU awards. |
| 12/06/2024 | Original grant date for subsequent RSU and PSU awards. |
| 12/10/2025 | Original grant date for most recent RSU award. |
| 06/04/2026 | Transaction date for the accrual of dividend equivalent rights. |
| 06/05/2026 | Filing date of the Form 4. |
Keywords
LeMaitre Vascular, LMAT, Form 4, Director, Dividend Equivalent Rights, Insider Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.